Every Monday we share a quick “best of” from the week that was in the world of women’s health innovation with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? Read on!
BIOMILQ’s $21M Series A and the Somewhat Controversial Lab-Grown Breast Milk Opportunity’
Last week U.S.-based mammary biotech company BIOMILQ announced a $21M Series A to accelerate commercialization of its lab-grown breast milk. Asked about the raise BIOMILQ Co-founder & CEO Michelle Egger shared: “While we’re thrilled to announce an oversubscribed series A, we’re more excited about the value beyond capital being added around the table from our new investors. Each partner brings technical expertise, passion for human and planetary health, and belief in female founded ventures.”
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
